ne sale to Global Infrastructure Partners +0.42%) +1.6%) Astrazeneca speculation that they have made a 1st round bid for Amylin (trading Roche's Actemra beats Abbott's Humira in Rheumatoid arthritis trials (trading Sports Direct eyeing up Umbro bid according to the Sunday Times (trading +0.20%) Euro